Litcius/Paper detail

Volanesorsen, an antisense oligonucleotide to apolipoprotein C-III, increases lipoprotein lipase activity and lowers triglycerides in partial lipodystrophy

Marissa Lightbourne, Megan Startzell, Kimberley D. Bruce, Brianna Brite, Ranganath Muniyappa, Monica C. Skarulis, Robert D. Shamburek, Ahmed M. Gharib, Ronald Ouwerkerk, Mary Walter, Robert H. Eckel, Rebecca J. Brown

2022Journal of clinical lipidology30 citationsDOIOpen Access PDF

Topics & Concepts

MedicineLipodystrophyLipoprotein lipaseApolipoprotein BInternal medicineEndocrinologyCholesterolAdipose tissueImmunologyHuman immunodeficiency virus (HIV)Antiretroviral therapyViral loadNuclear Structure and FunctionLipid metabolism and disordersDiabetes, Cardiovascular Risks, and Lipoproteins
Volanesorsen, an antisense oligonucleotide to apolipoprotein C-III, increases lipoprotein lipase activity and lowers triglycerides in partial lipodystrophy | Litcius